Overview
- NB.1.8.1, a SARS-CoV-2 variant driving surges in China, Hong Kong, and Taiwan, has been detected in travelers arriving at U.S. airports from nine countries.
- State health authorities in Ohio, Rhode Island, and Hawaii have reported cases of NB.1.8.1 dating back to late March and early April, separate from airport screenings.
- Preliminary research suggests the variant is not more immune-evasive but may be more transmissible due to stronger cell-binding capabilities.
- Hong Kong and Taiwan are responding to rising severe cases and hospitalizations by urging mask use and stockpiling medical resources.
- The FDA is deliberating updates to fall/winter COVID-19 vaccines, potentially targeting related JN.1 descendants like LP.8.1, which may cross-neutralize NB.1.8.1.